BioNxt Solutions为MS治疗开发了新的亚语言电影,目的是更好地吸收和方便。 BioNxt Solutions develops new sublingual film for MS treatment, aiming for better absorption and convenience.

BioNxt Solutions Inc.是药物交付的创新者,它成功地开发了一个新的亚语言薄膜原型,用于使用Cladribine处理多发硬化症。 BioNxt Solutions Inc., a drug delivery innovator, has successfully developed a new sublingual thin-film prototype for treating multiple sclerosis using cladribine. 这一进展在舌头下迅速消散,与传统方法相比,可以提供更好的药物吸收和便利。 This advancement, which dissolves quickly under the tongue, could offer better drug absorption and convenience compared to traditional methods. 该公司计划在今年晚些时候进行人类生物等值研究,以进一步完善产品。 The company plans to conduct human bioequivalence studies later this year to further refine the product.